DR. REDDY'S LABORATORIES LIMITED |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 78.47 USD | -2.45% |
|
+1.02% | +12.78% |
ETFs positioned on Dr. Reddy's Laboratories Limited
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 3.69% | 96 M€ | -.--% | - | |
| 1.76% | 11 M€ | -.--% | - | |
| 0.56% | 21 M€ | +11.03% | ||
| 0.01% | 114 M€ | +10.50% | - | |
| 0.00% | 32 M€ | +7.01% | - |
Dr. Reddy's Laboratories specializes in developing, producing, and selling pharmaceutical products. Net sales break down by activity as follows:
- sales of generic medications (79.9%): brand-name or generic prescription medications and OTC medicines;
- sales of active ingredients (15.7%). The group also supplies customized pharmaceutical services;
- other (4.4%): sales of generic biopharmaceutical products, development of molecular agents, etc.
Net sales are distributed geographically as follows: India (18.8%), the United States (45%), Russia (9.9%) and other (26.3%).
Sector
Pharmaceuticals
Calendar
2024-07-26
- Q1 2025 Earnings Release
Trading Rating
Investor Rating
ESG Refinitiv
Sell
Buy
Mean consensus
HOLD
Number of Analysts
36
Last Close Price
6,643
INR
Average target price
6,164
INR
Spread / Average Target
-7.21%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| +61.53% | 848B | |
| +34.19% | 627B | |
| -3.66% | 363B | |
| +15.06% | 318B | |
| +9.18% | 299B | |
| +11.25% | 234B | |
| +15.48% | 225B | |
| +15.67% | 179B | |
| +2.47% | 167B |
- Stock Market
- Equities
- DRREDDY Stock
- RDY Stock
- ETFs Dr. Reddy's Laboratories Limited
